Simulations Plus (SLP) AI-Driven Drug Design Collaboration Yields Positive Results
Simulations Plus, Inc. (NASDAQ:SLP) is one of the top 10 medical AI companies to buy according to analysts.
Simulations Plus Inc. (SLP)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Royce & Associates Chuck Royce | 265,000 | $4,624,250 | -19% | 0.05% |
| 2. | Prescott Group Capital Management Phil Frohlich | 80,000 | $1,396,000 | 0.16% | |
| 3. | Skylands Capital Charles Paquelet | 42,600 | $743,370 | 0.11% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $58.16 | 24,000 | $1,395,840.00 | 4,755,309 | 2020-08-26 | Filing | |
| $1.13 | 3,000 | $3,390.00 | 13,000 | 2009-05-15 | Filing | |
| $1.10 | 2,000 | $2,200.00 | 10,000 | 2009-05-14 | Filing | |
| $1.08 | 4,000 | $4,320.00 | 8,000 | 2009-05-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.93 | 867 | $11,210.31 | 9,930 | 2025-08-01 | Filing | |
| $18.58 | 12,224 | $227,121.92 | 3,304,157 | 2025-07-01 | Filing | |
| $17.94 | 7,776 | $139,501.44 | 3,316,381 | 2025-07-01 | Filing | |
| $31.36 | 100 | $3,136.00 | 3,324,157 | 2025-06-02 | Filing | |
| $30.57 | 1,000 | $30,570.00 | 3,324,257 | 2025-06-02 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,501,967 | $43,659,323 | 0% | |
| 2. | 1,282,143 | $22,373,387 | 0.33% | |
| 3. | 1,176,027 | $20,521,671 | 0% | |
| 4. | 485,404 | $8,469,778 | 0% | |
| 5. | 397,851 | $6,943,449 | 0% |
News See All
Top 10 Medical AI Companies to Buy According to Analysts
Artificial intelligence is transforming medical sciences in ways not seen before.
Conestoga Capital Advisors Trimmed Its Position in Simulations Plus (SLP)
Conestoga Capital Advisors, an asset management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
KeyBanc Downgrades Simulations Plus (SLP) Stock to Sector Weight
Simulations Plus, Inc. (NASDAQ:SLP) is one of the Best Beaten Down Stocks to Buy Now.
11 Best Beaten Down Stocks to Buy Now
J.P. Morgan Research believes that the S&P 500 will close near 6,000 by year-end, aided by the double-digit growth in earnings.
Simulations Plus, Inc. (NASDAQ:SLP) Q3 2025 Earnings Call Transcript
Operator: Greetings, and welcome to the Simulations Plus Third Quarter Fiscal 2025 Financial Results Conference Call. As a reminder, this conference call is being recorded.
Craig-Hallum Trims Simulations (SLP) Price Target, Maintaining a Buy Rating
Simulations Plus, Inc.
Top 10 Healthcare AI Stocks to Buy According to Hedge Funds
“Healthcare is the most underappreciated AI beneficiary,” said Ark Invest CEO Cathie Wood in a recent statement that’s reverberating across Wall Street.
Simulations Plus, Inc. (NASDAQ:SLP) Q2 2025 Earnings Call Transcript
Operator: Greetings, and welcome to the Simulations Plus Second Quarter Fiscal 2025 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Simulations Plus (SLP) Fell due to Concerns Over the Funding Environment
Wasatch Global Investors, an asset management company, released its “Wasatch Micro-Cap Growth-U.S. Strategy” third-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Billionaire Hedge Funds
